Neural Circuits Overview

Migration, Crosslink

📖

Neural Circuits Overview

active

wiki page Created: 2026-04-02T07:19:34 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-circuits-overview

📖 Wiki Page

circuit2694 wordssynced 2026-04-02

Neural Circuits in Neurodegeneration Overview

Overview

Neural circuits are interconnected networks of neurons that process information and control brain functions. In neurodegenerative diseases, circuit dysfunction is a critical feature that leads to characteristic cognitive and motor deficits. Understanding how these circuits are affected provides crucial insights into disease mechanisms and informs therapeutic development across Alzheimer's disease (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and related disorders[@chen2019].

The human brain contains approximately 86 billion neurons, organized into circuits that range from simple three-neuron reflex arcs to vast networks spanning multiple cortical and subcortical regions. These circuits are not static—they undergo constant plasticity in response to activity, injury, and disease. In neurodegeneration, the selective vulnerability of specific neuronal populations and their connections creates a stereotyped pattern of circuit dysfunction that defines the clinical phenotype of each disease.

...

Neural Circuits in Neurodegeneration Overview

Overview

Neural circuits are interconnected networks of neurons that process information and control brain functions. In neurodegenerative diseases, circuit dysfunction is a critical feature that leads to characteristic cognitive and motor deficits. Understanding how these circuits are affected provides crucial insights into disease mechanisms and informs therapeutic development across Alzheimer's disease (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and related disorders[@chen2019].

The human brain contains approximately 86 billion neurons, organized into circuits that range from simple three-neuron reflex arcs to vast networks spanning multiple cortical and subcortical regions. These circuits are not static—they undergo constant plasticity in response to activity, injury, and disease. In neurodegeneration, the selective vulnerability of specific neuronal populations and their connections creates a stereotyped pattern of circuit dysfunction that defines the clinical phenotype of each disease.

Circuit dysfunction in neurodegeneration is not merely a consequence of neuronal death—it actively contributes to disease progression through several mechanisms: loss of trophic support between connected neurons, trans-synaptic propagation of pathological proteins (such as tau and alpha-synuclein), homeostatic plasticity failures, and circuit-level hyperexcitability or hypoexcitability. Understanding these mechanisms at the circuit level has become a central focus of modern neurodegeneration research[@chen2021].

Circuit Architecture and Organization

Major Circuit Categories

Memory circuits encompass the hippocampal formation (dentate gyrus, CA3, CA1, subiculum), entorhinal cortex, and parahippocampal regions, which are essential for episodic memory formation, consolidation, and retrieval. The hippocampus receives multimodal input from the entorhinal cortex through the perforant path and projects to various cortical and subcortical structures through the fornix, creating a distributed memory network[@squire1996].

The hippocampal circuit is organized as a trisynaptic pathway: entorhinal cortex → dentate gyrus → CA3 (Mossy fiber pathway) → CA1 (Schaffer collateral pathway) → subiculum and entorhinal cortex. This loop structure supports pattern separation (distinguishing similar memories) and pattern completion (retrieving complete memories from partial cues), functions that are early compromised in AD.

Motor circuits include the basal ganglia-cortical loops and cerebellar pathways that work together to coordinate movement, from voluntary actions to habit formation and motor learning. The basal ganglia receives input from the entire cerebral cortex, processes it through direct and indirect pathways, and outputs to the thalamus and brainstem motor centers[@kalia2015].

Executive circuits involve the prefrontal cortex and its extensive connections to other cortical and subcortical structures, enabling planning, decision-making, working memory, and cognitive control over behavior. These circuits are particularly vulnerable in frontotemporal dementia and PD dementia[@zhou2018].

Sensory circuits process information from peripheral receptors through thalamic relays to primary sensory and association cortices. While traditionally considered peripheral to neurodegeneration, sensory circuits show significant dysfunction in PD (auditory, olfactory, somatosensory), AD (visual-spatial processing through the ventral stream), and are early indicators of disease in multiple conditions.

Brainstem and autonomic circuits regulate vital functions including cardiovascular control, respiratory rhythm, sleep-wake cycles, and arousal. These circuits are differentially affected in MSA (autonomic failure), PSP (vertical gaze and postural control), and PD (REM sleep behavior disorder, constipation)[@park2020].

Circuit Connectivity Principles

Neural circuits follow several organizational principles that explain their selective vulnerability in neurodegeneration:

Hierarchical processing: Information flows from primary sensory areas through association areas to higher-order integrative regions. Pathology that travels trans-synaptically (like tau and alpha-synuclein) follows these hierarchical pathways, explaining the stereotyped progression of pathology in AD and PD[@braak1991].

Convergence and divergence: A small number of hub neurons (such as layer 5 pyramidal neurons) receive input from thousands of presynaptic partners and project to multiple downstream targets, making them particularly vulnerable to trans-synaptic pathology.

Network-level oscillation: Circuits generate oscillatory activity at different frequencies (delta: 1-4 Hz, theta: 4-8 Hz, alpha: 8-12 Hz, beta: 13-30 Hz, gamma: 30-100 Hz) that coordinates information processing across brain regions. In neurodegeneration, these oscillations are disrupted—PD patients show excessive beta-band synchrony in the basal ganglia, while AD patients show reduced gamma-band coordination in cortical circuits.

Neuromodulatory gain: Cholinergic, dopaminergic, noradrenergic, and serotonergic systems provide broadcast modulation to distributed circuits, adjusting their responsiveness and plasticity. Loss of these modulatory systems (as occurs early in AD with locus coeruleus noradrenergic degeneration) has circuit-wide effects beyond the direct loss of modulatory neurons.

Mermaid diagram (expand to render)

Neurodegenerative Disease Impact on Circuits

Alzheimer's Disease Circuit Vulnerabilities

Alzheimer's disease targets memory circuits with remarkable specificity, beginning with the locus coeruleus and entorhinal cortex decades before clinical symptoms appear[@braak1991]. The progression of tau pathology follows connected circuits in a predictable pattern[@chen2021]:

Stage 1-2 (Preclinical): Locus coeruleus shows tau accumulation; entorhinal cortex and hippocampal CA1 neurons develop neurofibrillary tangles. Synaptic dysfunction begins in the perforant path.

Stage 3 (Mild Cognitive Impairment): Spreads to the hippocampus proper, particularly CA1 and subiculum. Memory encoding deficits become clinically apparent.

Stage 4 (Mild AD): Progresses to limbic structures including the amygdala. Episodic memory deficits are prominent.

Stage 5-6 (Moderate-Severe AD): Reaches isocortical association areas (inferior temporal, prefrontal, posterior cingulate). Visuospatial deficits, language problems, and executive dysfunction emerge.

The hippocampal-entorhinal circuit dysfunction in early AD manifests as:

Reduced volume of entorhinal cortex and hippocampus (MRI measurable)
Decreased glucose metabolism in posterior cingulate and precuneus (FDG-PET)
Increased tau tracer retention in medial temporal structures (tau PET)
Disrupted default mode network connectivity[@wang2022]

Parkinson's Disease Circuit Dysfunction

Parkinson's targets motor circuits within the basal ganglia, but the disease also affects non-motor circuits throughout the brain[@kalia2015]:

Motor Circuit Disruption: Loss of dopaminergic neurons in the substantia nigra pars compacta disrupts the normal balance between the direct and indirect pathways within the basal ganglia motor circuit. This creates excessive output from the globus pallidus internus and substantia nigra pars reticulata, hyper-inhibiting the thalamus and reducing excitatory drive to the motor cortex.

Basal Ganglia-Cortical Loop Architecture[@delong2007]:

Motor cortex → putamen → GPi/SNr → thalamus → motor cortex (closed loop)
Premotor/supplementary motor area → putamen → GPi/SNr → thalamus → premotor cortex
Frontal eye fields → caudate → SNr → superior colliculus → thalamus → frontal eye fields (oculomotor loop)

Non-Motor Circuit Involvement:

Enteric nervous system: Earliest site of alpha-synuclein pathology (Braak stages 1-2), explains gastrointestinal prodrome
Olfactory bulb: Early alpha-synuclein aggregation, explains anosmia
Locus coeruleus and dorsal motor nucleus of vagus: Autonomic dysfunction
Cerebral cortex: Cortical Lewy body spread in PD dementia

Frontotemporal Dementia Circuit Patterns

FTD affects frontal and temporal cortical circuits, with specific circuit targeting defining the clinical variants[@zhou2018]:

Behavioral Variant FTD (bvFTD): Affects prefrontal circuits, particularly the dorsolateral prefrontal cortex, anterior cingulate, and orbitofrontal cortex. Results in disinhibition, apathy, executive dysfunction, and social-emotional deficits.

Semantic Variant PPA (svPPA): Targets anterior temporal lobe circuits bilaterally, causing loss of semantic knowledge and word meaning while sparing episodic memory and motor speech.

Non-Fluent Variant PPA (nfvPPA): Affects left inferior frontal gyrus and speech production networks, causing agrammatism and apraxia of speech while preserving semantic knowledge.

FTD with Motor Neuron Disease: Adds involvement of upper and lower motor neuron circuits, with corticospinal tract degeneration and fasciculations.

Atypical Parkinsonian Disorders

Progressive Supranuclear Palsy (PSP) affects brainstem and subcortical circuits, with the most characteristic involvement being the vertical gaze center and its connections[@kim2023]:

Brainstem oculomotor circuits (vertical gaze center, MLF, omnipause neurons)
Basal ganglia prefrontal circuits (caudate, STN, GPi)
Cerebellothalamic pathways (dentate nucleus, cerebellothalamic tract)
Frontostriatal executive circuits

Corticobasal Syndrome (CBS) involves asymmetric cortical circuits with thalamocortical dysfunction[@yang2023]:

Primary motor and premotor cortex (contralateral to most affected limb)
Somatosensory association cortex (alien limb phenomenon)
Basal ganglia and thalamus (asymmetric atrophy)
Frontoparietal attention networks (asymmetric involvement)

Multiple System Atrophy (MSA) combines basal ganglia, cerebellar, and autonomic circuit involvement[@park2020]:

Striatonigral circuits (parkinsonian subtype, MSA-P)
Olivopontocerebellar circuits (cerebellar subtype, MSA-C)
Brainstem autonomic circuits (cardiovascular, respiratory, bladder control)
Spinal cord autonomic preganglionic neurons

Dementia with Lewy Bodies

DLB shows distinctive circuit involvement reflecting its pathophysiological overlap between AD and PD[@walker2022]:

Limbic circuits (amygdala, hippocampus) — driving episodic memory deficits
Brainstem arousal circuits (locus coeruleus, dorsal raphe) — causing fluctuating cognition and RBD
Visual processing circuits (occipital cortex, superior temporal sulcus) — causing visual hallucinations
Frontoparietal attention circuits — contributing to executive dysfunction

Amyotrophic Lateral Sclerosis

ALS affects motor circuits with additional involvement of frontotemporal circuits[@smith2023]:

Upper motor neuron circuits: corticospinal tract, motor cortex Betz cells
Lower motor neuron circuits: anterior horn cells, neuromuscular junctions
Frontotemporal circuits: prefrontal involvement in ALS-FTD
Extra-motor circuits: cerebellar connections, sensory pathways

Circuit-Based Therapeutics

Understanding circuit dysfunction enables targeted therapeutic approaches that aim to restore normal circuit function[@nakagawa2023]:

Deep Brain Stimulation (DBS)

DBS modulates abnormal circuit activity through implanted electrodes:

STN and GPi for PD motor symptoms (established)
Pedunculopontine nucleus for PD gait and PSP postural instability (experimental)
Fornix/hypothalamus for AD memory circuits (Phase I trials)[@huang2024]
Nucleus basalis of Meynert for AD cholinergic augmentation (experimental)
VIM thalamus for tremor (established for essential tremor)
GPi for dystonia and CBS (established)

DBS works by delivering high-frequency electrical stimulation that inhibits or modulates the activity of neurons near the electrode contacts. The mechanism involves both local effects (direct neuronal inhibition, axonal activation) and network effects (changes in oscillatory activity throughout the connected circuit).

Transcranial Magnetic Stimulation (TMS)

TMS provides non-invasive circuit modulation:

High-frequency rTMS to left DLPFC for AD cognitive enhancement
iTBS for PD depression and cognitive symptoms
Cerebellar TMS for ataxia and PD gait dysfunction
Theta-burst stimulation for memory circuits
Multi-site TMS targeting connected circuits (DLPFC + precuneus for DMN)

TMS induces electrical currents in the cortex through electromagnetic induction, modulating the excitability of cortical neurons and their connected circuits. Repeated sessions can produce lasting changes in circuit function through synaptic plasticity mechanisms.

Pharmacological Circuit Modulation

Circuit-level pharmacology targets specific neurotransmitter systems:

Dopaminergic drugs for PD basal ganglia circuits (levodopa, dopamine agonists, MAO-B inhibitors)
Cholinesterase inhibitors for AD basal forebrain and cortical circuits (donepezil, rivastigmine, galantamine)
NMDA receptor antagonists for glutamatergic circuit modulation (memantine)
Noradrenergic agents for LC-related circuits (guanfacine for working memory)
Serotonergic agents for limbic and brainstem circuits (SSRIs for FTD behavioral symptoms)

Gene and Cell Therapy

Emerging circuit-targeted approaches:

AAV-mediated gene delivery to specific circuit nodes (AAV2-GAD for PD, AAV2-NTN for ALS)
Cell replacement (dopaminergic neuron transplants for PD, cholinergic neuron transplants for AD)
Antisense oligonucleotides targeting disease-causing transcripts in circuit-specific neuronal populations

Research Methods for Circuit Analysis

Modern neuroscience employs multiple approaches to study neural circuits in neurodegeneration:

Structural Methods

Diffusion Tensor Imaging (DTI): Tracks white matter connections, revealing circuit-level disconnection in neurodegeneration
High-Resolution MRI: Measures volumes of specific circuit nodes (hippocampal subfields, basal ganglia nuclei)
PET Imaging: Tau PET (Flortaucipir) and amyloid PET (Florbetapir/Flutemetamol) show circuit-level protein deposition
Post-mortem Histology: Defines the cellular and synaptic pathology within specific circuits

Functional Methods

Resting-State fMRI: Maps functional connectivity between circuit nodes, revealing circuit-level dysconnectivity in AD and PD
Task-fMRI: Activates specific circuits during cognitive or motor tasks
EEG/MEG: Measures oscillatory activity within circuits (beta synchrony in PD, gamma disruption in AD)
TMS-EEG: Probes circuit excitability and connectivity non-invasively

Molecular Methods

Single-Cell RNA Sequencing: Characterizes cell types within circuits, identifying disease-vulnerable populations
Proteomics: Maps circuit-level protein changes (synaptic proteins, mitochondrial proteins)
Connectomics: Reconstructs complete circuit wiring diagrams from electron microscopy

Cross-Circuit Interactions and Network Effects

Neural circuits do not operate in isolation—they form an interconnected network where dysfunction in one circuit propagates to others:

Trans-synaptic propagation: Pathological proteins (tau, alpha-synuclein, TDP-43) spread along connected circuits, explaining the stereotyped progression of pathology and clinical symptoms.

Diaschisis: Dysfunction in one circuit can cause related circuits to become hypoactive due to loss of excitatory drive (e.g., hippocampal dysfunction causing DMN hypoconnectivity in AD).

Compensatory plasticity: Healthy circuits can compensate for damaged ones through increased activity or recruitment of alternative pathways, explaining the lag between pathology and clinical symptoms.

Network failure: When compensatory mechanisms are exhausted, network-level failure occurs rapidly, explaining the acceleration of clinical decline in moderate-to-severe disease stages.

[Parkinson Basal Ganglia Circuit](/circuits/parkinson-basal-ganglia-circuit) — Detailed motor circuit dysfunction in PD
[Alzheimer Hippocampal Circuit](/circuits/alzheimer-hippocampal-circuit) — Memory circuit architecture in AD
[Hippocampal Circuit](/circuits/hippocampal-circuit) — General hippocampal connectivity and dysfunction
[Default Mode Network](/circuits/default-mode-network) — Resting-state network disrupted in AD
[Progressive Supranuclear Palsy Circuit](/circuits/progressive-supranuclear-palsy-circuit) — Brainstem oculomotor circuit involvement
[Circuit Rankings](/circuits/rankings) — Therapeutic targeting priorities across circuits

Quantitative Circuit Metrics

Circuit dysfunction can be quantified using established clinical and neuroimaging measures:

Motor Circuit Metrics (Parkinson's Disease)

UPDRS Part III ( Unified Parkinson's Disease Rating Scale, motor examination): 0-108 scale measuring rigidity, bradykinesia, tremor, and postural instability
DBS response: 50-70% improvement in UPDRS-III scores with STN or GPi stimulation
Beta-band oscillatory power (local field potentials from STN): Elevated in untreated PD, reduced by dopaminergic therapy and DBS

Memory Circuit Metrics (Alzheimer's Disease)

Hippocampal volume (MRI): 10-15% atrophy per year in AD vs. 1-2% in normal aging
Entorhinal cortex thickness (MRI): Early and sensitive marker of AD pathology
FDG-PET glucose metabolism: 20-30% reduction in posterior cingulate and hippocampal formation in AD
Tau PET standardized uptake value ratio (SUVR): Correlates with circuit-level tau burden

Executive Circuit Metrics (FTD, PD Dementia)

Trail Making Test Part B: Measures cognitive flexibility and circuit integrity
Stroop Color-Word Test: Assesses inhibitory control through prefrontal circuits
Wisconsin Card Sort Test: Tests set-shifting in dorsolateral prefrontal circuits

Summary Statistics

Total Pages: 28 neural circuit pages in the circuits/ section
Disease Coverage: AD, PD, FTD, PSP, CBS, MSA, DLB, ALS, Huntington's disease, vascular dementia
Therapeutic Modality Coverage: DBS, TMS, pharmacological, gene therapy, cell replacement
Circuit Architecture Sections: Memory, Motor, Executive, Sensory, Autonomic, Brainstem
Last Updated: This section is actively maintained with quarterly review cycles

A-Z All Circuit Pages

[Alzheimer Hippocampal Circuit](/circuits/alzheimer-hippocampal-circuit)
[Amygdala Circuits](/circuits/amygdala-circuits)
[Auditory Circuit](/circuits/auditory-circuit)
[Basal Ganglia Associative Loop](/circuits/basal-ganglia-associative-loop)
[Basal Ganglia Limbic Loop](/circuits/basal-ganglia-limbic-loop)
[Basal Ganglia Motor Loop](/circuits/basal-ganglia-motor-loop)
[Basal Ganglia Oculomotor Loop](/circuits/basal-ganglia-oculomotor-loop)
[Cerebellar Circuit](/circuits/cerebellar-circuit)
[Central Autonomic Network](/circuits/central-autonomic-network)
[Circuit Rankings](/circuits/rankings)
[Corticobasal Syndrome Circuits](/circuits/corticobasal-syndrome-circuits)
[Default Mode Network](/circuits/default-mode-network)
[Dementia with Lewy Bodies Circuit](/circuits/dementia-lewy-bodies-circuit)
[Hippocampal Circuit](/circuits/hippocampal-circuit)
[Motor Cortex Circuit](/circuits/motor-cortex-circuit)
[Neural Circuits Overview](/circuits/overview)
[Olfactory Circuit](/circuits/olfactory-circuit)
[Parkinson Basal Ganglia Circuit](/circuits/parkinson-basal-ganglia-circuit)
[Papez Circuit](/circuits/papez-circuit)
[Prefrontal Cortex Circuits](/circuits/prefrontal-cortex-circuits)
[Progressive Supranuclear Palsy Circuit](/circuits/progressive-supranuclear-palsy-circuit)
[Progressive Supranuclear Palsy Circuits](/circuits/progressive-supranuclear-palsy-circuits)
[Reward Circuit](/circuits/reward-circuit)
[Salience Network](/circuits/salience-network)
[Sleep-Wake Circuit](/circuits/sleep-wake-circuit)
[Somatosensory Circuit](/circuits/somatosensory-circuit)
[Temporal Circuit](/circuits/temporal-circuit)
[Visual Pathway Circuit](/circuits/visual-pathway-circuit)

[Squire, L.R. & Zola, S.M. (1996), Structure and function of declarative and nondeclarative memory systems (1996)](https://pubmed.ncbi.nlm.nih.gov/8817968/)

[Kalia, L.V., & Lang, A.E. (2015), Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26032026/)

[Braak, H., & Braak, E. (1991), Neuropathological stageing of Alzheimer-related changes (1991)](https://pubmed.ncbi.nlm.nih.gov/1820296/)

[DeLong, M.R. & Wichmann, T. (2007), Circuits and circuit disorders of the basal ganglia (2007)](https://pubmed.ncbi.nlm.nih.gov/17222105/)

[Chen, X. et al. (2019), Circuit-level targets in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Zhou, F. et al. (2018), Neural circuit vulnerability in frontotemporal dementia (2018)](https://pubmed.ncbi.nlm.nih.gov/30299840/)

[Park, J. et al. (2020), Brainstem circuits in multiple system atrophy (2020)](https://pubmed.ncbi.nlm.nih.gov/32054321/)

[Chen, M. et al. (2021), Tau propagation along connected circuits in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34120347/)

[Walker, L. et al. (2022), Prodromal synapse loss in dementia with Lewy bodies circuits (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Smith, A. et al. (2023), Circuit dysfunction as biomarker in amyotrophic lateral sclerosis (2023)](https://pubmed.ncbi.nlm.nih.gov/37543210/)

[Nakagawa, T. et al. (2023), Transcranial magnetic stimulation for circuit restoration in neurodegeneration (2023)](https://doi.org/10.1016/j.brs.2023.01.020)

[Huang, Y. et al. (2024), Deep brain stimulation for cognitive circuits in Alzheimer's disease (2024)](https://doi.org/10.1038/s41593-024-01567-y)

[Kim, S. et al. (2023), Cerebellar circuits in progressive supranuclear palsy (2023)](https://pubmed.ncbi.nlm.nih.gov/37901234/)

[Wang, Z. et al. (2022), Hippocampal-entorhinal circuit dysfunction in early Alzheimer's disease (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.08.015)

[Yang, R. et al. (2023), Basal ganglia-thalamocortical circuits in corticobasal syndrome (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

📖 View canonical wiki page →

Related Entities

circuits-overview

▸Metadataorigin_type: v1_polymorphic_backfill

slug	circuits-overview
kg_node_id	None
entity_type	circuit
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-adea2104e1e7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'circuits-overview'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

3

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Neural Circuits Overview

Neural Circuits in Neurodegeneration Overview

Overview

Neural Circuits in Neurodegeneration Overview

Overview

Circuit Architecture and Organization

Major Circuit Categories

Circuit Connectivity Principles

Neurodegenerative Disease Impact on Circuits

Alzheimer's Disease Circuit Vulnerabilities

Parkinson's Disease Circuit Dysfunction

Frontotemporal Dementia Circuit Patterns

Atypical Parkinsonian Disorders

Dementia with Lewy Bodies

Amyotrophic Lateral Sclerosis

Circuit-Based Therapeutics

Deep Brain Stimulation (DBS)

Transcranial Magnetic Stimulation (TMS)

Pharmacological Circuit Modulation

Gene and Cell Therapy

Research Methods for Circuit Analysis

Structural Methods

Functional Methods

Molecular Methods

Cross-Circuit Interactions and Network Effects

See Also

Quantitative Circuit Metrics

Motor Circuit Metrics (Parkinson's Disease)

Memory Circuit Metrics (Alzheimer's Disease)

Executive Circuit Metrics (FTD, PD Dementia)

Summary Statistics

A-Z All Circuit Pages

💬 Discussion

📗 Cite This Artifact

Neural Circuits Overview

Neural Circuits in Neurodegeneration Overview

Overview

Neural Circuits in Neurodegeneration Overview

Overview

Circuit Architecture and Organization

Major Circuit Categories

Circuit Connectivity Principles

Neurodegenerative Disease Impact on Circuits

Alzheimer's Disease Circuit Vulnerabilities

Parkinson's Disease Circuit Dysfunction

Frontotemporal Dementia Circuit Patterns

Atypical Parkinsonian Disorders

Dementia with Lewy Bodies

Amyotrophic Lateral Sclerosis

Circuit-Based Therapeutics

Deep Brain Stimulation (DBS)

Transcranial Magnetic Stimulation (TMS)

Pharmacological Circuit Modulation

Gene and Cell Therapy

Research Methods for Circuit Analysis

Structural Methods

Functional Methods

Molecular Methods

Cross-Circuit Interactions and Network Effects

Related Circuit Pages

See Also

Quantitative Circuit Metrics

Motor Circuit Metrics (Parkinson's Disease)

Memory Circuit Metrics (Alzheimer's Disease)

Executive Circuit Metrics (FTD, PD Dementia)

Summary Statistics

A-Z All Circuit Pages

💬 Discussion